Tottenham Acquisition I today in an amended preliminary proxy filing set Dec. 30 as the date for a shareholder vote on the SPAC’s proposed merger with Clene Nanomedicine.
If approved, the $542.5 million deal would merge the two companies into a newly formed business named PubCo. Read more.
Related Posts
CF Acquisition IV Calls Meeting to Vote on 6-Month Deadline Extension
If approved, the SPAC's sponsor would deposit the lesser of $500,000 or 4.5 cents a share into trust for each month of the extension.
Maquia Capital Acquisition Pushes Extension Vote Back by 2 Days
In a separate press release, the SPAC also disclosed today that it is "working diligently" toward a merger agreement with a target in the fintech sector.
Trajectory Alpha Acquisition Sells Sponsor Stake
Trajectory Alpha faces a June 14 termination deadline, although a shareholder meeting is set for June 8, when investors will consider an extension until March 2024.
CHP Merger Changes Accounting for Warrants
CHP raised $250 million in an October 2019 IPO to target US healthcare companies.